Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze PHBI stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate PHBI investment potential.

What is PHBI stock price today?

Get real-time PHBI stock price, historical data, and price charts on Financhill. Track PHBI performance with our advanced analysis tools.

Is PHBI a good investment?

Evaluate PHBI investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy PHBI stock?

To buy PHBI stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of PHBI?

View detailed market capitalization data and company valuation metrics for PHBI on our comprehensive analysis page.

What is the P/E ratio of PHBI?

Use our fundamental analysis tools to view PHBI P/E ratio and compare valuation metrics with industry peers.

What are PHBI earnings?

View PHBI earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Pharmagreen Biotech, Inc. 10K Form

Buy

PHBI
Pharmagreen Biotech, Inc.

Last Price:

$0.0000

Seasonality Move:

56.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-06-10	10K	PHBI/Pharmagreen Biotech, Inc. Annual
2021-05-24	10Q	PHBI/Pharmagreen Biotech, Inc. Quarterly
2021-02-23	10Q	PHBI/Pharmagreen Biotech, Inc. Quarterly
2021-02-22	10Q	PHBI/Pharmagreen Biotech, Inc. Quarterly
2021-01-08	10K	PHBI/Pharmagreen Biotech, Inc. Annual
2020-08-19	10Q	PHBI/Pharmagreen Biotech, Inc. Quarterly

Receive PHBI News And Ratings

See the #1 stock for the next 7 days that we like better than PHBI

PHBI Financial Statistics

Sales & Book Value

Annual Sales:	$3.4K
Cash Flow:	$-3.8K
Price / Cash Flow:	0
Annual Sales:	$0.00
Price / Book:	0

Profitability

EPS (TTM):	0.00000
Net Income (TTM):	$-234.4K
Gross Margin:	$1.1K
Return on Equity:	0%
Return on Assets:	-240.07%

Pharmagreen Biotech, Inc. Earnings Forecast

Key Pharmagreen Biotech, Inc. Financial Ratios

The Gross Profit Margin over the past 10 years for PHBI is 32.35%.
The Selling, General & Administrative Expenses for PHBI have been equal to 791.18% of Gross Profit Margin.
The Net Earning history of PHBI is -29,541.18% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 6 years.

Pharmagreen Biotech, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	PHBI
Website:	pharmagreen.ca

Debt

Debt-to-Equity Ratio:	-0.14
Current Ratio:	0.04
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

PHBI Technical Analysis vs Fundamental Analysis

Buy

Pharmagreen Biotech, Inc. (PHBI) is a Buy

Is Pharmagreen Biotech, Inc. a Buy or a Sell?

Pharmagreen Biotech, Inc. stock is rated a Buy

The current Pharmagreen Biotech, Inc. [PHBI] share price is $0.0026. The Score for PHBI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.